Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Noninvasive Detection of High Grade Prostate Cancer by DNA Methylation Analysis of Urine Cells Captured by Microfiltration

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Active surveillance for localized prostate cancer. Nationwide, observational study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Sexual function in a nationwide cohort of 2260 testicular cancer survivors after 17 years follow-up

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Editorial Comment

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  1. Does treatment of the primary tumor in oligometastatic postate cancer matter?

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  2. Detection of prostate cancer by DNA analysis of filtration-captured cells from urine

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  3. Multiparametric MRI predicts adverse pathological prostate cancer features in patients eligible for active surveillance.

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  4. Multiparametric MRI in Active Surveillance

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

Vis graf over relationer

PURPOSE: With the aim of developing a noninvasive test to detect clinically significant prostate cancer we investigated the potential of capturing cells from urine by microfiltration coupled with analysis of DNA methylation biomarkers.

MATERIALS AND METHODS: In this prospective study urine from men suspected of having prostate cancer who were scheduled for transrectal ultrasound guided biopsy of the prostate was collected before digital rectal examination in 99, after digital rectal examination in 58 and from a urethral catheter in 7. Cells were isolated from whole volume voided urine using a filtration device containing a membrane filter with a pore size of 8 μm. Ten additional men provided 4 or 5 urine cell samples by self-collection prior to biopsy. Cellular DNA was analyzed for 5 methylation biomarkers using ddPCR™ (droplet digital polymerase chain reaction).

RESULTS: Prostate cancer was diagnosed in 117 patients (71%). Across all tumor grades the sensitivity of urine DNA testing was 81% and 60% in samples obtained before and after digital rectal examination, respectively. In a prediction model including prostate specific antigen, patient age and the result of urine DNA analysis to detect high grade disease (Gleason score 7 or greater) an AUC of 0.95 (95% CI 0.90-1.00) was obtained for post-digital rectal examination samples. Analysis of repeat samples demonstrated substantial intraindividual variation in the shedding of cancerous cells in urine.

CONCLUSIONS: Capturing cells from urine by microfiltration provides a novel tool to detect prostate cancer noninvasively with high sensitivity for high grade disease. Repeat sampling may increase sensitivity, particularly when urine is obtained without prior physical manipulation of the prostate.

OriginalsprogEngelsk
TidsskriftThe Journal of urology
Vol/bind200
Udgave nummer4
Sider (fra-til)749-757
Antal sider9
ISSN0022-5347
DOI
StatusUdgivet - okt. 2018

ID: 56755396